The benefits of flash glucose monitoring in the UK


  • Masa Josipovic
  • Mark Evans


Author Biographies

Masa Josipovic

Gates Trust Cambridge Scholar/ PhD Student, Wellcome Trust/ MRC Institute of Metabolic Science, University of Cambridge, Cambridge UK

Mark Evans

University Professor of Diabetic Medicine and Honorary Consultant Physician, Wellcome Trust/ MRC Institute of Metabolic Science & Department of Medicine, University of Cambridge, Cambridge UK


McKnight JA, Wild SH, Lamb MJE, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 2015;32(8):1036–50.

Shah VN, Grimsmann JM, Foster NC, et al. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow‐up (Germany/Austria) registries. Diabetes Obes Metab 2020;22(9):1577–85.

Health Technology Wales (HTW) Guidance 004-2 (July 2021).

Secher AL, Pedersen-Bjergaard U, Svendsen OL, et al. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial. Diabetologia 2021;64(12):2713–24.

Wilmot EG, Evans M, Barnard-Kelly K, et al. Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol. BMJ Open 2021;11(7):e050713.

Evans M, Welsh Z, Ells S, Seibold A. The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies. Diabetes Ther Res Treat Educ Diabetes Relat Disord 2020;11(1):83–95.

Jeyam A, Gibb FW, McKnight JA, et al. Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study. Diabetologia 2021 Oct 7. [Online ahead of print].

Deshmukh H, Wilmot EG, Choudhary P, et al. Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists Nationwide Audit. Diabetes Care 2021;44(11):e190–e191.

Heller SR, Gianfrancesco C, Taylor C, Elliott J. What are the characteristics of the best type 1 diabetes patient education programmes (from diagnosis to long‐term care), do they improve outcomes and what is required to make them more effective? Diabet Med 2020;37(4):545–54.

Hopkins D, Lawrence I, Mansell P, et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: The UK DAFNE experience. Diabetes Care 2012;35(8):1638–42.

DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325(7367):746.

National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. NICE Guideline 17. 2015.